AbbVie : ABBV

All AbbVie Articles

616 Articles

Jon C. Ogg | Oct 31, 2016 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include AbbVie, Chevron, Home Depot, Nike, Qualcomm and VMware.

Chris Lange | Oct 28, 2016 at 10:05 AM EDT

AbbVie Slides on Top-Line Miss

AbbVie reported mixed third-quarter financial results and a dividend hike before the markets opened on Friday.

Lee Jackson | Oct 28, 2016 at 9:50 AM EDT

Jefferies Adds Top Financial Stock to Franchise Picks Portfolio

Four companies in four very different sectors that all offer liquidity, a degree of safety and solid dividends that should…

Chris Lange | Oct 26, 2016 at 7:40 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Oct 23, 2016 at 10:35 AM EDT

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of…

Lee Jackson | Oct 13, 2016 at 10:40 AM EDT

Top 5 Jefferies Big Pharma Stock Picks for Q4

A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good…

Chris Lange | Oct 12, 2016 at 7:35 AM EDT

Major Pharma Short Sellers Grow More Selective

The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…

Lee Jackson | Oct 6, 2016 at 9:50 AM EDT

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

In a new research report from Jefferies, many of the outstanding companies in pharmaceuticals and biotech space show up among…

Lee Jackson | Sep 30, 2016 at 8:25 AM EDT

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less…

Chris Lange | Sep 27, 2016 at 7:40 AM EDT

Major Pharma Continues to See Rising Tide in Short Interest

The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Sep 26, 2016 at 8:35 AM EDT

Jefferies Makes Huge New Stock Addition to Franchise Picks List

In a recent research note, the analysts at Jefferies make a big move by adding a top technology company to…

Jon C. Ogg | Sep 26, 2016 at 8:15 AM EDT

How Much Will Consumers Save on New Humira Biosimilar?

In a time when government wrangling about drug prices is more than commonplace, news of a biosimilar for the mega-blockbuster…

Lee Jackson | Sep 20, 2016 at 8:20 AM EDT

4 Jefferies Large Cap Franchise Picks That Also Pay Solid Dividends

Most Wall Street strategists agree that the way to play the fourth quarter and next year is with large cap…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Chris Lange | Sep 13, 2016 at 7:25 AM EDT

Major Pharma Continues to See Significant Drop in Short Interest

The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

1 … 28 29 30 31 32 … 42

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

AbbVie Slides on Top-Line Miss

Jefferies Adds Top Financial Stock to Franchise Picks Portfolio

Short Sellers Grow More Selective on Major Pharma Stocks

Top Health Care Earnings Coming Next Week

Top 5 Jefferies Big Pharma Stock Picks for Q4

Major Pharma Short Sellers Grow More Selective

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Major Pharma Continues to See Rising Tide in Short Interest

Jefferies Makes Huge New Stock Addition to Franchise Picks List

How Much Will Consumers Save on New Humira Biosimilar?

4 Jefferies Large Cap Franchise Picks That Also Pay Solid Dividends

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

AbbVie : ABBV

All AbbVie Articles

Top Analyst Upgrades and Downgrades: AbbVie, Chevron, Home Depot, Nike, Qualcomm, VMware and More

AbbVie Slides on Top-Line Miss

Jefferies Adds Top Financial Stock to Franchise Picks Portfolio

Short Sellers Grow More Selective on Major Pharma Stocks

Top Health Care Earnings Coming Next Week

Top 5 Jefferies Big Pharma Stock Picks for Q4

Major Pharma Short Sellers Grow More Selective

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Major Pharma Continues to See Rising Tide in Short Interest

Jefferies Makes Huge New Stock Addition to Franchise Picks List

How Much Will Consumers Save on New Humira Biosimilar?

4 Jefferies Large Cap Franchise Picks That Also Pay Solid Dividends

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Major Pharma Continues to See Significant Drop in Short Interest

The American Chip Boom Picks Winners: TXN, INTC, and QRVO at Current Share Prices

NVIDIA is Acquiring ‘Dark Fiber’ Across the United States. Here’s Why That’s a Big Deal.

SpaceX Just Erased $1 Trillion in Value. Here’s Why the Worst Could Be Yet to Come.

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account